Natavudh Townamchai
Overview
Explore the profile of Natavudh Townamchai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
609
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Thammathiwat T, Banjongjit A, Iampenkhae K, Townamchai N, Kanjanabuch T
Vaccines (Basel)
. 2023 May;
11(5).
PMID: 37243087
Vaccines against SARS-CoV-2 (COVID-19) proved beneficial for COVID-19 disease attenuation and preventing virus spreading. Cumulative reports of the rarity of antineutrophil cytoplasmic autoantibodies (ANCA)-associated vasculitis (AAV) raise concerns about its...
12.
Banjongjit A, Wuttiputhanun T, Vanichanan J, Ueaphongsukkit T, Iampenkhae K, Avihingsanon Y, et al.
Kidney Int
. 2023 Mar;
103(4):801-802.
PMID: 36948774
No abstract available.
13.
Santithanmakorn C, Vanichanan J, Townamchai N, Jutivorakool K, Wattanatorn S, Sutherasan M, et al.
Biomedicines
. 2022 Nov;
10(11).
PMID: 36428552
Risk factors and consequences of urinary tract infection (UTI) post-kidney transplant have been variously reported by studies that were heterogenous in immunosuppressants and prophylactic protocols. We aimed to clarify the...
14.
Nuchjumroon A, Vadcharavivad S, Singhan W, Poosoonthornsri M, Chancharoenthana W, Udomkarnjananun S, et al.
J Clin Med
. 2022 Nov;
11(21).
PMID: 36362548
A high intra-patient variability (IPV) of tacrolimus exposure is associated with poor long-term kidney transplantation outcomes. To assess the influence of cytochrome P450 (CYP) 3A5 genetic polymorphisms on tacrolimus IPV,...
15.
Phirom S, Phannajit J, Jantarabenjakul W, Paitoonpong L, Kitrungphaiboon T, Choktaweesak N, et al.
Transplant Direct
. 2022 Oct;
8(11):e1393.
PMID: 36312516
Methods: The kidney transplant recipients who were enrolled into the study were divided into 2 groups based on their immunosuppressive regimen. Those on the standard immunosuppressive regimen received tacrolimus (TAC),...
16.
Banjongjit A, Phirom S, Phannajit J, Jantarabenjakul W, Paitoonpong L, Kittanamongkolchai W, et al.
Vaccines (Basel)
. 2022 Oct;
10(10).
PMID: 36298550
Kidney transplant recipients (KTRs) have a suboptimal immune response to COVID-19 vaccination due to the effects of immunosuppression, mostly mycophenolic acid (MPA). This study investigated the benefits of switching from...
17.
Updated management for antibody-mediated rejection: opportunity to prolong kidney allograft survival
Townamchai N, Avihingsanon Y
Curr Opin Nephrol Hypertens
. 2022 Oct;
32(1):13-19.
PMID: 36250450
Purpose Of Review: Antibody-mediated rejection (ABMR) is an important barrier to achieve long-term kidney allograft survival. Human leukocyte antibody (HLA)-incompatibility and ABO-incompatibility are the two main mechanisms of ABMR. Nevertheless,...
18.
Banjongjit A, Lertussavavivat T, Paitoonpong L, Putcharoen O, Vanichanan J, Wattanatorn S, et al.
Transplantation
. 2022 Oct;
106(12):e520-e521.
PMID: 36190207
No abstract available.
19.
Banjongjit A, Tiabrat V, Avihingsanon Y, Townamchai N
J Nephrol
. 2022 Sep;
35(9):2441-2442.
PMID: 36063290
No abstract available.
20.
Tiankanon K, Kerr S, Thongthip S, Udomkarnjananun S, Sodsai P, Vorasittha A, et al.
Sci Rep
. 2022 Jun;
12(1):10051.
PMID: 35710816
Twice daily TAC (BID TAC) and prolonged released once daily dose tacrolimus (OD TAC) have different pharmacokinetic (PK) profiles in kidney transplant (KT) recipients. Precise dose adjustment recommendations when converting...